Antidepressant Prescribing Patterns in the Nursing Home: Second-Generation Issues Revisited

Journal of the American Medical Directors Association

Volumn 13, Issue 4, 2012, Pages 406.e13-406.e18

  Shah, Shruti ^a   Schoenbachler, Ben ^b   Streim, Joel ^c   Meeks, Suzanne ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antidepressants; Medical chart documentation; Nursing homes; Prescribing patterns

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ARTICLE; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD REVIEW; NURSING HOME; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; RETROSPECTIVE STUDY; TREATMENT DURATION; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 84860321857     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2011.09.004     Document Type: Article

References (34)

1. Jones R.N., Marcantonio E.R., Rabinowitz T. Prevalence and correlates of recognize depression in U.S. nursing homes. J Am Geriatr Soc 2003, 51:1404-1409.
2. NIH Consensus Developmental Panel on Depression in Late Life. Diagnosis and treatment of depression in late life. JAMA 1992, 268:1018-1024.
3. Gaboda D., Lucas J., Siegal M., et al. No longer undertreated? Depression diagnosis and antidepressant therapy in elderly long-stay nursing home residents, 1999-2007. J Am Geriatr Soc 2011, 59:673-680.
4. Jeste D.V., Alexopolous G.S., Bartels S.J., et al. Consensus statement on the upcoming crisis in geriatric mental health. Arch Gen Psychiatry 1990, 56:848-853.
5. Brown M.N., Lapane K., Luisi A.F. The management of depression in older nursing home residents. J Am Geriatr Soc 2002, 50:69-72.
6. Heston L.L., Gerrard J., Makris L., et al. Inadequate treatment of depressed nursing home elderly. J Am Geriatr Soc 1992, 40:1117-1122.
7. Omnibus Reconciliation ACT of 1987. Pub. L. No. 100-103, 4201(a), 4211(a).
8. Cohen-Mansfield J., Lipson S., Gruber-Baldini A.L., et al. Longitudinal prescribing patterns of psychotropic drugs in nursing home residents. Exp Clin Psychopharmacol 1996, 4:224-233.
9. Garrard J., Dunham T., Markis L., et al. Longitudinal study of psychotropic drug use by elderly nursing home residents. J Gerontol 1992, 47:183-188.
10. Karki S.D., Patterson W.R., Masood G. Usage patterns of antidepressant medications in a community nursing home. Annals Long Term Care 1999, 7:364-368.
11. Ruths S., Staand J., Nygaard H.A. Psychotropic drug use in nursing homes-diagnostic indications and variation between institutions. Eur J Clin Pharm 2001, 57:523-528.
12. Cherma M.D., Lofgren U., Almkvist G., et al. Assessment of the prescription of antidepressant drugs in elderly nursing home patients. J Clin Psychopharmacol 2008, 28:424-431.
13. Datto C.J., Oslin D.W., Streim J.E., et al. Pharmacological treatment of depression in nursing home residents: A mental health services perspective. J Geriatr Psychiatry Neurol 2002, 15:141-146.
14. Weintraub D., Datto C.J., Streim J.E., et al. Second-generation issues in the management of depression in nursing homes. J Am Geriatr Soc 2002, 50:2100-2101.
15. Brink T.L., Yesavage J.A., Lum O., et al. Screening tests for geriatric depression. Clinical Gerontologist 1982, 1:37-44.
16. Lapane K.L., Hughes C.M. Which organizational characteristics are associated with increased management of depression using antidepressants in US nursing homes?. Med Care 2004, 42:992-1000.
17. Zisselman M.H., Allen G.D., Cutillo-Schmitter T., et al. The minimum data set and psychotropic drug use in nursing home residents. Ann Long Term Care 1998, 6:199-205.
18. Simmons S.F., Cadogan M.P., Cabrera G.R., et al. The Minimum Data Set Depression Quality Indicator: Does it reflect differences in care processes?. Gerontologist 2004, 44:554-564.
19. Datto CJ, Streim JE, Difilippo S, et al. Quality of depression treatment in the long term care setting. Paper presented at: the Annual Meeting of the American Association of Geriatric Psychiatry; March 2003; Honolulu, HI.
20. Centers for Medicare & Medicaid Services. Nursing Home Compare [Data file]. Available at: Accessed November, 17 2009. http://www.medicare.gov/NHCompare.
21. Karkare S.U., Bhattacharjee S., Kamble P., et al. Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. Am J Geriatr Pharmacother 2011, 9:109-119.
22. Klysner R., Bent-Hansen J., Hansen H.L., et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: Placebo-controlled study of maintenance therapy. Br J Psychiatry 2002, 181:29-35.
23. Roose S.P., Nelson J.C., Salzman C., et al. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home. Curr Med Res Opin 2003, 19:737-746.
24. Weintraub D., Streim J.E., Datto C.J., et al. Effect of increasing the dose and duration of sertraline trail in the treatment of depressed nursing home residents. J Geriatr Psychiatry Neurol 2003, 16:109-111.
25. Rosenberg P.B., Drye L.T., Martin B.K., et al. Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry 2010, 18:136-145.
26. Weintraub D., Rosenberg P.B., Drye L.T., et al. Sertraline for the treatment of depression in Alzheimer disease: Week-24 outcomes. Am J Geriatr Psychiatry 2010, 18:332-340.
27. Culang M.E., Sneed J.R., Keilp J.G., et al. Change in cognitive functioning following acute antidepressant treatment in late-life depression. Am J Geriatr Psychiatry 2009, 17:881-888.
28. Sneed J.R., Culang M.E., Keilp J.G., et al. Antidepressant medication and executive dysfunction: A deleterious interaction in late-life depression. Am J Geriatr Psychiatry 2010, 18:128-135.
29. Llewellyn-Jones R.H., Snowden J. Depression in nursing homes: Ensuring adequate treatment. CNS Drugs 2007, 21:627-640.
30. Conn D.K., Madan R. Use of sleep-promoting medications in nursing homes residents: Risks versus benefits. Drugs Aging 2008, 23:271-287.
31. Goldberg R.J. Weight change in depressed nursing home patients on mirtazapine. J Am Geriatr Soc 2002, 50:1461-1467.
32. Sietz D.P., Adunuri N., Gill S.S., et al. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev 2011, 16. CD008191.
33. Snowdon J. Depression in nursing homes. Int Psychogeriatr 2010, 22:1143-1148.
34. Saliba D, Buchanan J. Development & Validation of a Revised Nursing Home Assessment Tool: MDS 3.0. Rand Health Corporation; 2008. Available at: Accessed June 9, 2011. http://www.cms.hhs.gov/NursingHomeQualityInits/downloads/MDS30FinalReport.pdf.